DataKnowledgeCloudtrainingcoordination

COL Q91VX2-1 GLY 000631 (Collection)

Taxon:

Mus musculus

Taxonomy (Entity type)

Protein:

UBAP2 MOUSE

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Compound:

N-ACETYL-beta-D-GLUCOSAMINE

Compound (Entity type)

Collection:

mouse proteoform glycosylation sites oglcnac mcw.csv

File (Entity type)

Description:Information for protein Q91VX2-1 in the context of file GLY_000631

Creation Time:2026-03-02 20:00:38.000000

Results found

Linked to

	Label	Description
	q91vx2-1 659thr 659thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q91vx2-1 642ser 642ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q91vx2-1 1018ser 1018ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q91vx2-1 631ser 631ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	UBAP2 MOUSE Protein (Entity type)	Ubiquitin-associated protein 2
	q91vx2-1 652ser 652ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q91vx2-1 1117ser 1117ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q91vx2-1 877ser 877ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q91vx2-1 401ser 401ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q91vx2-1 392ser 392ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

Post Translational Modification

q91vx2-1 659thr 659thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q91vx2-1 642ser 642ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q91vx2-1 1018ser 1018ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q91vx2-1 631ser 631ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Protein

UBAP2 MOUSE

Protein (Entity type)

Ubiquitin-associated protein 2

Post Translational Modification

q91vx2-1 652ser 652ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q91vx2-1 1117ser 1117ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q91vx2-1 877ser 877ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q91vx2-1 401ser 401ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q91vx2-1 392ser 392ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.